{"id":2204631,"date":"2022-07-31T13:08:33","date_gmt":"2022-07-31T11:08:33","guid":{"rendered":"http:\/\/nhub.news\/?p=2204631"},"modified":"2022-08-01T15:53:13","modified_gmt":"2022-08-01T13:53:13","slug":"scientists-question-pfizers-paxlovid-data-after-biden-tests-positive-for-covid-19-again","status":"publish","type":"post","link":"http:\/\/nhub.news\/fr\/2022\/07\/scientists-question-pfizers-paxlovid-data-after-biden-tests-positive-for-covid-19-again\/","title":{"rendered":"Scientists Question Pfizer&#039;s Paxlovid Data After Biden Tests Positive for COVID-19 Again"},"content":{"rendered":"<p style=\"text-align: justify;\"><b>Array<\/b><br \/>\nPresident Joe Biden posted a video after he tested positive for COVID-19 again saying that he\u2019s \u201cfeeling fine\u201d as scientists have speculated that Paxlovid-associated rebound cases are more common than initially suspected.<br \/>\u201cHey folks, Joe Biden here. Tested positive this morning. Going to be working from home for the next couple of days. And I\u2019m feeling fine, everything\u2019s good. But Commander and I got a little work to do,\u201d Biden said in the video posted to Twitter late on Saturday. He was referring to his dog, Commander.<br \/>White House Doctor Dr. Kevin O\u2019Connor wrote in a letter on Saturday, in confirming Biden\u2019s diagnosis, that people who take Paxlovid can test positive for the virus after testing negative.<br \/>\u201cAs described last week, acknowledging the potential for so-called \u2018rebound\u2019 COVID positivity observed in a small percentage of patients treated with PAXLOVID the President increased his testing cadence, both to protect people around him and to assure early detection of any return of viral replication,\u201d O\u2019Connor said. Now,\u00a0Biden will engage in \u201cstrict isolation procedures,\u201d O\u2019Connor added.<br \/>Biden tested positive again for COVID-19 on Saturday morning after using an antigen test, the letter said. It comes days after he returned a negative test and delivered a speech at the White House.<br \/>Dr. Jonathan Reiner, a prominent cardiologist and professor of medicine at George Washington University Hospital wrote that he believes that \u201cCOVID rebound\u201d cases sparked by taking Paxlovid are quite common.<br \/>\u201cThe prior data suggesting \u2018rebound\u2019 Paxlovid positivity in the low single digits is outdate[d] and with BA.5 is likely 20-40 percent or even higher,\u201d Reiner\u00a0wrote on Twitter in response to Biden\u2019s second positive test. He did not provide a study or data to back up his Twitter post.<br \/>And Eric Topol, a physician and scientist, said that \u201cPaxlovid rebound is quite common \u2026 a retrospective study using [electronic health records] of 11,270 people before BA.5 that suggests it\u2019s 5 percent is way off the mark,\u201d he wrote. Topol was citing a National Institutes of Health-published study from last month.<br \/>\u201cThe actual incidence can only be meaningfully assessed through a prospective study conducted directly with participants with frequent testing. This is in progress. Whether longer than 5 days treatment will reduce the rate also needs to be determined by a RCT (5 vs 10d),\u201d Topol wrote Sunday.<br \/>But White House COVID-19 coordinator Ashish Jha has denied that Paxlovoid rebound numbers are 40 percent or more. The actual percentage, he claimed, is \u201cin the single digits.\u201d<br \/>\u201cIf you look at Twitter, it feels like everybody has rebound, but it turns out there\u2019s actually clinical data,\u201d he said last week. \u201cIf you look at major health systems that have given out Paxlovid to tens of thousands of people, rebound rates are around 5 percent. There are some studies that say it\u2019s maybe 7-8 percent, some that say it\u2019s 2 percent, but it\u2019s in the single digits. So it happens; it\u2019s not that frequent.\u201d<br \/>\u201cWhen people have rebound, they don\u2019t end up in the hospital. They don\u2019t end up particularly sick,\u201d Jha added. \u201cPaxlovid is working really well at preventing serious illness, rebound or no rebound, and that\u2019s why he was offered it. And that\u2019s why the president took it.\u201d<br \/>Earlier this year, White House medical adviser Anthony Fauci also took Paxlovid for a COVID-19 case. After four days of negative tests, Fauci, 81, said he tested positive for the virus.<br \/>Weeks before that, the U.S. Centers for Disease Control and Prevention issued an alert to health providers about rebound cases associated with Paxlovid, which is made by Pfizer.<br \/>\u201cPaxlovid continues to be recommended for early-stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease,\u201d said the agency in a notice posted in June. \u201cPaxlovid treatment helps prevent hospitalization and death due to COVID-19. COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms or a new positive viral test after having tested negative.\u201d<br \/>Pfizer, in its marketing literature, has said there is a 2 percent chance of a patient getting COVID-19 rebound symptoms from Paxlovid. The Epoch Times has contacted Pfizer for comment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Array President Joe Biden posted a video after he tested positive for COVID-19 again saying that he\u2019s \u201cfeeling fine\u201d as scientists have speculated that Paxlovid-associated rebound cases are more common than initially suspected.\u201cHey folks, Joe Biden here. Tested positive this morning. Going to be working from home for the next couple of days. And I\u2019m [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2204630,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[113],"tags":[],"_links":{"self":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/2204631"}],"collection":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/comments?post=2204631"}],"version-history":[{"count":0,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/2204631\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/media\/2204630"}],"wp:attachment":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/media?parent=2204631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/categories?post=2204631"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/tags?post=2204631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}